J FrontierJ Frontier Co.,Ltd.2934東証グロース情報・通信業FY ending May 2026, consolidated, J-GAAP
About 45% of J Frontier's sales come from Healthcare marketing business, with Healthcare sales business and Medical care sales business making up much of the rest.
Out of every ¥100 of sales, about ¥1 is left as operating profit.
Revenue changed +21.4% from the prior year, and it swung back to an operating profit.
FY ending May 2024 → FY ending May 2025
FY ending May 2024 → FY ending May 2025
For every ¥100 J Frontier sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
EDINET (FSA Japan)
有価証券報告書-第18期(2025/06/01-2026/05/31)
EDINET (FSA Japan)
有価証券報告書-第17期(2024/06/01-2025/05/31)
EDINET (FSA Japan)
訂正有価証券報告書-第16期(2023/06/01-2024/05/31)
EDINET (FSA Japan)
訂正有価証券報告書-第15期(2022/06/01-2023/05/31)
EDINET (FSA Japan)
有価証券報告書-第14期(令和3年6月1日-令和4年5月31日)
EDINET (FSA Japan)
有価証券報告書-第13期(令和2年6月1日-令和3年5月31日)
Extracted from XBRL: 50 / Derived from other figures: 2
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.